Literature DB >> 16157343

Lethal and severe coronary arteritis in DBA/2 mice induced by fungal pathogen, CAWS, Candida albicans water-soluble fraction.

Noriko Nagi-Miura1, Toshie Harada, Hiroyasu Shinohara, Kiyoshi Kurihara, Yoshiyuki Adachi, Akiko Ishida-Okawara, Toshiaki Oharaseki, Kei Takahashi, Shiro Naoe, Kazuo Suzuki, Naohito Ohno.   

Abstract

CAWS is a microbial pathogen-associated molecular patterns (PAMPs) produced by Candida albicans. CAWS is a mannoprotein-beta-glucan complex and secreted into the culture supernatant. CAWS has various biological effects, causing acute shock and disrupting vascular permeability. Intraperitoneal administration of CAWS induces coronary arteritis in various strains of inbred mice. The CAWS-induced coronary arteritis is strain-dependent and most severe in DBA/2 mice with a significant number of these animals expiring with cardiomegaly during the observation period. In vivo and in vitro, splenocytes of DBA/2 mice produced various cytokines, such as IL-6, TNF-alpha, and IFN-gamma in response to CAWS. GM-CSF was also produced in response to CAWS. The production of cytokines was significantly enhanced in the presence of recombinant GM-CSF. In contrast, anti-GM-CSF significantly reduced the production of TNF-alpha and IFN-gamma. Augmented production of cytokines in response to CAWS would be a key to the severity of coronary arteritis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16157343     DOI: 10.1016/j.atherosclerosis.2005.08.014

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  14 in total

1.  Tropospheric winds from northeastern China carry the etiologic agent of Kawasaki disease from its source to Japan.

Authors:  Xavier Rodó; Roger Curcoll; Marguerite Robinson; Joan Ballester; Jane C Burns; Daniel R Cayan; W Ian Lipkin; Brent L Williams; Mara Couto-Rodriguez; Yosikazu Nakamura; Ritei Uehara; Hiroshi Tanimoto; Josep-Anton Morguí
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-19       Impact factor: 11.205

2.  Correlation of atherogenesis with an infection of Candida albicans.

Authors:  Maya J Nurgeldiyeva; Bayram G Hojakuliyev; Merdan B Muhammedov
Journal:  Int J Clin Exp Med       Date:  2014-08-15

3.  Vasculitis: molecular imaging by targeting the inflammatory enzyme myeloperoxidase.

Authors:  Henry S Su; Matthias Nahrendorf; Peter Panizzi; Michael O Breckwoldt; Elisenda Rodriguez; Yoshiko Iwamoto; Elena Aikawa; Ralph Weissleder; John W Chen
Journal:  Radiology       Date:  2011-11-14       Impact factor: 11.105

4.  Triptolide as an Alternative to IVIG Therapy for Kawasaki Disease in a Mouse Model.

Authors:  Zong-Ting Yan; Jian-Wen Zou
Journal:  Balkan Med J       Date:  2013-06-01       Impact factor: 2.021

Review 5.  The microbiome in autoimmune rheumatic disease.

Authors:  Maximilian F Konig
Journal:  Best Pract Res Clin Rheumatol       Date:  2020-02-07       Impact factor: 4.098

6.  The involvement of the vasa vasorum in the development of vasculitis in animal model of Kawasaki disease.

Authors:  Akiko Hamaoka-Okamoto; Chinatsu Suzuki; Tomoyo Yahata; Kazuyuki Ikeda; Noriko Nagi-Miura; Naohito Ohno; Yoshinori Arai; Hideo Tanaka; Tetsuro Takamatsu; Kenji Hamaoka
Journal:  Pediatr Rheumatol Online J       Date:  2014-03-30       Impact factor: 3.054

7.  GM-CSF primes cardiac inflammation in a mouse model of Kawasaki disease.

Authors:  Angus T Stock; Jacinta A Hansen; Matthew A Sleeman; Brent S McKenzie; Ian P Wicks
Journal:  J Exp Med       Date:  2016-09-05       Impact factor: 14.307

8.  A Model of Left Ventricular Dysfunction Complicated by CAWS Arteritis in DBA/2 Mice.

Authors:  Naoto Hirata; Ken-Ichi Ishibashi; Tatsuya Usui; Jiro Yoshioka; Satoru Hata; Yoshiyuki Adachi; Noriko Nagi-Miura; Shin Ohta; Naohito Ohno
Journal:  Int J Vasc Med       Date:  2012-07-08

9.  Etanercept suppresses arteritis in a murine model of kawasaki disease: a comparative study involving different biological agents.

Authors:  Ryuji Ohashi; Ryuji Fukazawa; Makoto Watanabe; Hanako Tajima; Noriko Nagi-Miura; Naohito Ohno; Shinichi Tsuchiya; Yuh Fukuda; Shunichi Ogawa; Yasuhiko Itoh
Journal:  Int J Vasc Med       Date:  2013-03-31

10.  CAWS administration increases the expression of interferon γ and complement factors that lead to severe vasculitis in DBA/2 mice.

Authors:  Noriko Nagi-Miura; Daisuke Okuzaki; Kosuke Torigata; Minami A Sakurai; Akihiko Ito; Naohito Ohno; Hiroshi Nojima
Journal:  BMC Immunol       Date:  2013-09-24       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.